MYM Nutraceuticals Inc. has appointed Dr. Brigitte Simons (PhD and eMBA) as the Responsible Person in Charge (RPIC) and Quality Assurance Person (QAP). She is one of the few experts in technical quantitative reporting using mass spectrometry, a technology that is used to deliver accurate potency and testing of cannabis products. Most recently, Dr. Simons was Vice President of Laboratories and Operations at Molecular Science Corp.

Effective immediately, Howard Steinberg will step down as President, Chief Executive Officer, and member of the audit and compensation committees for MYM. Mr. Steinberg will remain as chairman of the board of directors. The day to day operations of the business will fall to Robin Linden who has been appointed President and Chief Executive Officer.

Mr. Linden has been with MYM since 2016 and was appointed to the board of directors in 2017, serving several positions within the Company. Ted Tabisz has been appointed interim Chief Financial Officer in place of Mr. Linden and will continue as a Director of the Company.